Skip to main content
. 2021 Mar 23;11:6685. doi: 10.1038/s41598-021-86021-8

Figure 2.

Figure 2

In vitro synergy of YHO-1701 in combination with already-available targeted agents for a total of 33 “combination + cell line” pairs. Drug interactions (synergism or antagonism) were analyzed using the combination index (CI) method. The antiproliferative effect of YHO-1701 and/or molecular-targeted agents was evaluated in a human cancer cell line panel using the WST-8 assay at 48 or 72 h of exposure. CI values were calculated and represented as a synergy “heat map” where a drug combination is synergistic (pink color) if CI ≤ 0.9; additive (white color) if CI is 0.9–1.1; and antagonistic (gray color) if CI > 1.1.